Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chronic Obstructive Pulmonary Disease
Clinical Trial Data: Safety/Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD
November 9th, 2007
COPD is the fourth leading cause of death in America, behind heart disease, cancer and stroke. Twelve million Americans have been diagnosed with COPD and at least another 12 million have symptoms but are not diagnosed. COPD is not well understood or recognized – most Americans have not heard of it, not even those who may be living with the condition. The most common cause of COPD is cigarette smoking, which is responsible for an estimated 80 to 90 percent of COPD cases. Estimates of the total incidence of COPD in America range from 24 to 30 million. About Nebulization Of the three types of devices used to deliver bronchodilators – nebulizers, metered-dose...
Source: Biotech Law Weekly (2007-11-09)
|
